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Abstract
Thymic epithelial cells (TEC) are essential for a proper adaptive immune response by
regulating thymocyte development and establishing central tolerance. In the thymus, TECs
differentially express Wnt proteins, which activate canonical and non-canonical Wnt signaling
pathways. Wnt signaling is thought to regulate cell survival, proliferation, and development
although the direct molecular mechanisms in TECs have yet to be elucidated. The inducible
inhibition of canonical Wnt signaling with Dkk1 leads to a rapid loss of TEC progenitors as well
as a decline in mature Aire-expressing mTECs. Therefore, we explore the role of Wnt ligands
potentially responsible for stimulating and/or regulating Wnt signaling in TECs by analyzing the
genetic expression of various TEC populations in TCF/Lef:H2B/GFP Wnt reporter mice. Here
we show that previously uncharacterized populations of postnatal mTECs undergoing canonical
Wnt signaling differentially express Wnt proteins and we further identify Wnt-5a and Wnt-5b as
possible candidates for regulating Wnt signaling in mTECs. It is well known that developing
thymocytes indirectly affect TEC development—in order to study the effects of Wnt stimulation
on TECs, we generate fetal thymic organ cultures (FTOC) in which we eliminate the developing
thymocytes and instead use exogenous RANKL to drive TEC specific maturation, while
simultaneously culture the TECs with different Wnt proteins. Our results show that the Wnt
antagonist, Sfrp-1, and the Wnt ligand, Wnt-5b, interfere with RANKL-induced maturation as
demonstrated by a reduced frequency of Aire+ fetal TECs. Furthermore, we show two proteins
that are hallmarks of thymic development, FoxN1 and Dll4, regulate Wnt-5b genetic expression
in vitro. However, further work is needed to determine if Wnt-5b is affecting TEC development
through canonical or non-canonical Wnt signaling and whether the modulation is due to an
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altering of cell-fate, increased apoptosis, or by the preservation of cells in an undifferentiated
state.
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Introduction
Overview of T-cell and Thymic Development
In humans, the thymus consists of two semi-identically sized lobes positioned behind the
sternum and overlies the pericardium and the great vessels at the base of the heart [39]. The
thymus serves as a specialized primary lymphoid organ that recruits T-cell precursors from the
bone marrow and supports the differentiation and selection of T-cells that express a functional,
self-tolerant T-cell antigen receptor (TCR). Well studied for their essential role in the thymic
microenvironment, thymic epithelial cells (TEC) construct branching, 3-D architectural niches in
the thymus and create appropriate microenvironments for T-cell development and selection to
occur [38]. Most importantly, TECs are critical in the establishment of central tolerance—the
immune system’s ability to distinguish self from non-self—for T-cell adaptive immunity [40-42].
In the thymus, expression of the TCR is initiated by the lymphoid specific RAG1/2 proteins in a
process known as VDJ recombination [44] and this process results in the production of a diverse
repertoire (1014-1018) of TCRs capable of recognizing the almost infinite array of protein
peptides, or antigens, that foreign entities produce. Once in the periphery, following a rigorous
selection process that removes cells expressing self-reactive TCRs, mature T-cells wield their
TCRs to identify pathogens, like viruses and bacteria, and can stimulate an immune response
[43].
Organogenesis of the murine thymus begins by E11.0 when the third pharyngeal pouch
(3rd pp) of the endodermal gut begins to pocket outwards [45]. The thymus-specific transcription
factor, forkhead box N1 (FoxN1), generally marks the emergence of the thymic epithelium and is
essential for proliferation and differentiation of thymic epithelial progenitor cells (TEPC) [45,
46]. This is evidenced by the fact that mice with a genetic mutation in the FoxN1 gene, called
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Nude mice, do not develop a competent thymus [45, 47]. Yet, other factors needed for TEC
lineage development from the fetal endoderm are poorly understood, as are regulators of TEPC
homeostasis and differentiation in the adult thymus [60]. In addition, an assortment of growth
and developmental signals are expressed in the early thymus, revealing a complex molecular
symphony of signals necessary for appropriate thymic function [38]. Some of these signals—
tumor necrosis factor super family (TNFSF) and WNT—will be discussed in more detail.
T-cells develop from multipotent hematopoietic stem cells (HSC) that migrate to the
thymus through the cardiovascular system [48]. During embryonic development, HSCs derive
from the fetal liver; in adults, they derive from bone marrow [77, 38, 81, 79]. Inside the thymus,
the T-cell developmental progress can be tracked through the expression of certain membranebound molecules, particularly CD4 and CD8 [49]. When describing thymic organogenesis and
development, it is important to include developing thymocytes because their interaction with
thymic epithelium is required for correct TEC development. In a process termed cross-talk, the
signals thymocytes and TECs give and receive in cell-cell interactions are essential for the
development and maintenance of both cell types. One without the other results in an abnormal
thymus, interrupted thymocyte development, and increased risk for autoimmunity [50-53].
The thymus can be divided into three architectural compartments: the cortex, the medulla,
and the loosely defined border between the cortex and medulla known as the cortico-medullary
junction (CMJ). Following chemokine signals, early thymic progenitor (ETP) cells enter into the
thymus at the CMJ from the circulatory system [77, 38, 81, 79]. Developing thymocytes are then
trafficked through different thymic microenvironments during distinctive steps in their
maturation program [38, 48, 49]. T-cell development in the thymus, is an intricate, multi-step
process that includes T-cell commitment, proliferation, differentiation, selection, and migration
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[38, 79]. Yet, most developing thymocytes (95%) are expunged and do not leave the thymus to
become mature effector T-cells [48, 80].
Cortical thymic epithelial cells (cTEC) secrete chemokines to attract ETPs from the CMJ
to the cortex. There, ETPs are first induced by Dll4 and IL-7 to differentiate into immature
double-negative (DN) thymocytes, which do not express the TCR co-receptors CD4 or CD8 [82,
83, 48, 50]. DN thymocytes are classified by four progressing phases each characterized by the
expression of surface markers CD44 and CD25, and during which VDJ recombination takes
place [38, 48, 49, 81]. Only a small population of ETPs enters the thymus, so this population
undergoes a process of extreme growth during the DN1 and DN2 stages of thymocyte
development [17, 84, 85]. By the end of the DN3 stage, the immature thymocyte develops a preTCR [81]. Eventually, the thymocyte forms a functional TCR and expresses both TCR coreceptors, CD4 and CD8, known as a double-positive (DP) T-cell [48, 49]. In a process called
major histocompatibility complex class (MHC) restriction, the cTECs positively select DP
thymocytes by exposing their TCR to a peptide-MHC complex in the context of either MHCI,
which is recognized by CD8, or MHCII, which is recognized by CD4 [48, 49, 78]. The positive
selection event results in single-positive (SP) thymocytes that exclusively express either CD4 or
CD8 [48, 49, 78]. Thymocytes that do not form a functional TCR, and therefore cannot interact
with cTECs presenting self-antigens, eventually die off in a process called death by neglect [48,
87, 88].
After positive selection, SP thymocytes increase their expression of the chemokine
receptor CCR7 [35]. This prompts their migration to the thymic medulla, which is facilitated by
medullary thymic epithelial cells (mTEC) that express CCL21 and CCL19, the ligands for CCR7
[35, 48]. In the medulla, a specialized molecular process called promiscuous gene expression
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(pGE) allows mTECs and thymic dendritic cells (tDC) to present tissue-restricted self-antigens
(TRA)—antigens intrinsic to other organs, tissues, and cells in the organism—to SP thymocytes
[89-93]. Collectively, mTECs are able to express almost all known protein-coding genes [89-93].
SP thymocytes with TCRs that respond too intensely with TRAs are either negatively selected by
mTECs and deleted by directed suicide through apoptosis, or are induced to differentiate into
regulatory T-cell subsets [89-93].
The responsibility of pGE in mTECs is essential in the establishment of central tolerance.
One of the best-studied proteins directing pGE is the nuclear protein autoimmune regulator
(Aire), which can up-regulate over a thousand genes in mTECS [89-93]. In humans, a mutation
to the Aire gene results in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
(APECED), a serious autoimmune disease [93]. Likewise, Aire KO mice failed to establish
central tolerance and suffer multiorgan autoimmunity [93]. In addition to its critical role in
mTEC TRA presentation, Aire is also involved in the production of regulatory T-cells and
controls mTEC secretion of XCL1, a chemokine that contributes to the accrual of tDCs [95].
The cortex and medulla are functionally distinct compartments that express a composite
of surface, cytoplasmic, and nuclear proteins. Individually, mTECs and cTECs employ unique
genetic and molecular programs that effectively govern thymus homeostasis and thymocyte
progression. Though, both mTECs and cTECs express many molecules in common (MHC-I,
MHC-II, EpCAM-1, CD40, LTβR, FoxN1), they are recognized in flow cytometry and
immunohistology by cell-specific protein expression [38]. In general, cTECs are often identified
by the expression of K8, K18, β5t, CD205, Cathepsin-L, CCRL1, and Dll4 [48]. While K5, K14,
MTS10, Aire, CD80, CD86, RANK, UEA1, Cathepsin-S, and Claudin3/4 are used to identify
mTECs [38].
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Expectedly, the levels of cell-surface-protein expression change during the development
and maturation of TECs, and this has been well studied by flow cytometry analysis. In brief,
TEC surface-protein expression by flow cytometer analysis of enzymatically digested thymus
preparations routinely defines all TECs as CD45-EpCAM+ [38]. cTECs and mTECs are further
purified by the expression of Ly-51+ or UEA-1+ respectively [38]. mTECs are then subdivided
into two populations based on the protein expression levels of MHC-II and CD80. Immature
mTECs, or mTEClo cells express UEA-1+CD80-MHC-IIlo while more mature mTECs, or mTEChi
cells express UEA-1+CD80+MHC-IIhi. Analysis of the mTEC compartment during embryonic
thymus development using CD80 and MHC-II expression showed that mTEClo cells appear prior
to the emergence of mTEChi cells, suggesting a possible precursor product relationship between
these two cell populations [38, 96, 97]. Nonetheless, TEPC lineage to cTECs and mTECs
remains unclear. In embryonic mouse thymus, one study identified a single bipotent TEC
progenitor capable of generating cTECs and mTECs [60, 61], but other studies identified lineage
specific mTEC and cTEC progenitor cells [62-64].
Aire is thought to be a defining marker in mTEC differentiation. Aire expression was
only found in a rare population of mTEChi cells and 5-bromo-2`deoxyuridine (BrdU)
experiments showed that Aire+ mTECs were postmitoic, derived from cycling Aire- precursors,
and induced apoptosis of mTECs [96, 97]. Thus, some argue that Aire expression can also be
viewed as a terminal differentiation marker for mTECs [96, 97]. On the other hand, Aire does
not act alone in pGE and Aire-independent mature mTECs exist. For example, the transcriptional
regulator Fezf2 was shown to drive pGE in mTECs through a pathway independent of Aire and
the TRAs regulated by Fezf2 differ from those regulated by Aire [94].
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Overview of NF-κB Signaling
TNFSF members have important roles in innate and adaptive immunity, including the
generation and maintenance of the thymic microenvironment. Moreover, RANKL, TNFα, and
αLTβR all activate NF-κB responsive genes in mTECs in unique and overlapping ways [98].
Briefly, Mammalian NF-κB transcription factors consist five homologous subunits (Rela/p65, cRel, RelB, p50/NF-κB1, and p52/NF-κB2), which exist in unstimulated cells as homo- and
heterodimers that are held in the cytoplasm by IκB family proteins to prevent translocation to the
nucleus [144]. A common feature to all NF-κB proteins is that they include a Rel-homology
domain (RHD) that contains a nuclear localization sequence that is involved in dimerization and
sequence-specific DNA binding [145, 146]. Immediately upstream from the IκB-bound NF-κB
dimers is the IKK complex, which is comprised of two catalytic, IKKα and IKKβ, and one
regulatory, IKKγ/NF-κB essential modulator (NEMO) subunits [144]. Several signaling
pathways converge to activate the IKK complex, which then phosphorylates NF-κB-bound IκB
proteins that target the IκB protein for ubiquitination and degradation by the 26S proteasome by
creating a binding site for Skp1-Cullin1-F-box protein (SCF)/β-TrCP ubiquitin ligase complex
[144]. The now free NF-κB dimers translocate into the nucleus and activate transcriptional target
genes. NF-κB signaling is commonly described as two recognized pathways, the canonical
pathway and the non-canonical pathway. The canonical pathway generally depends on NEMO,
IKKβ activation, and nuclear translocation of the RelA/p50 dimers to induce target gene
expression, while the non-canonical pathway generally depends on IKKα activation and nuclear
localization of p52/RelB heterodimers [145].
In the thymus, Aire expression in mTECs depends on cross talk with thymocytes. T-cells
that form successful TCRs receive survival signals from the thymic stroma and are induced to
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express TNFSF cytokines (RANKL, CD40L, TNFα, and αLTβR) [34, 98]. TNFSF receptors
expressed by TECs interact with the cytokines expressed by thymocytes to drive TEC
proliferation and differentiation [34, 97, 98]. Double KO transgenic mice for RANK and CD40
resulted in the onset of T-cell mediated autoimmune diseases [99]. RANK and RANKL KO mice
exhibited no mature mTECs in the embryonic thymus and a severely reduced number of
postnatal mature mTECs [97, 100]. Recently, microarray gene profiles of fetal thymic organ
cultures (FTOC)—FTOCs are in-vitro assays used to study the development of thymocytes
and/or TECs—independently stimulated with different TNFSF cytokines revealed that RANKL
alone was directly and specifically responsible for the expression of Aire in mTECs [98]. The
exact molecular mechanisms surrounding RANKL induced Aire expression is incomplete and
evidence suggests that both canonical and non-canonical NF-κB signaling pathways are
involved; though recent data argues that the canonical NF-κB pathway is responsible for the
induction of Aire expression [98, 101].
Overview of Wnt Signaling
Wnt proteins play diverse but a crucial role during the development, differentiation, cell
migration, and proliferation in vertebrate and invertebrates, and the misregulation of Wnt
signaling often leads to cancer and metastasis [29]. In vertebrates specifically, Wnt signaling is
known to regulate cell fate, establishment of the dorsal axis, limb development, asymmetric cell
division, progenitor-cell proliferation and survival, and long-tem memory formation [17].
Moreover, Wnt signaling has also been shown to regulate the maintenance of hematopoietic and
epithelial stem cells [17]. Presently, there are 19 known Wnt genes in the human genome and
they all encode lipid-modified secreted glycoproteins that usually bind to 10 known, seventransmembrane receptors of the Frizzled (Fzd) family [17, 139]. It is widely accepted that the
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Wnt signaling is separated into three different intracellular pathways: the canonical Wnt or βcatenin-dependent pathway, the planar cell polarity pathway (PCP) or Wnt-Jun N-terminal
kinase pathway, and the Wnt-Ca2+ pathway. Pathway specificity seemingly comes from a
particular combination of Wnt ligands, Fzd receptors, co-receptors, and even intracellular
signaling components [29]. Yet, this is poorly understood since the combinations are frequently
context, organ, and species specific, and because multiple Wnt ligands or Fzd receptors have
redundant roles in activating multiple Wnt pathways.
The most well-known and understood pathway is called the canonical Wnt pathway and
involves β-catenin and members of the T-cell factor (TCF)/lymphocyte-enhancer-binding factor
(LEF) family [17]. The canonical Wnt signaling cascade exists in two main phases, active and
inactive. In the absence of a Wnt ligand binding to its Fzd receptor complex, or inactive phase,
cytoplasmic and nuclear β-catenin levels are minimal since it is targeted for degradation by the
proteasome through the actions of a destruction complex [17]. The destruction complex is
composed of two scaffolding and tumor-suppressor proteins adenomatous polyposis coli (APC)
and axis inhibition protein 1 (AXIN1), and the serine/threonine kinase 1 (CSNK1A1) and
glycogen synthase kinase 3β (GSK3β) [17]. CSNK1A1 phosphorylates β-catenin on Ser45, and
then GSK3β phosphorylates β-catenin on Ser33, Ser37 and Thr41, creating recognition sites for
β-transducin-repeat-containing protein (βTRCP) [23], and tagging β-catenin for ubiquitinationdependent proteolysis [19]. Meanwhile, in the nucleus, TCF assembles a transcriptional repressor
complex comprised of Groucho/Transducin-like enhancer (GRG/TLE), C-terminal binding
protein (CTBP), and histone deacetylases (HDACs) in order to silence Wnt target genes [20].
The canonical Wnt activation is initiated by a Wnt ligand binding to its Fzd receptor
complex and results in the cytoplasmic stabilization and accumulation of β-catenin, which
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subsequently translocates to the nucleus and coordinates transcriptional activity [17]. Wnt
ligands bind to its Fzd receptor and its co-receptor, low density lipoprotein receptor related
protein 5 (LRP5) or 6 (LRP6), at the cell membrane to activate the signaling cascade [17].
Dishevelled (DVL) then forms a complex with Fzd/LRP and promotes the phosphorylation of
LRP5/6 by CSNK1A1 or GSK3β [21], which recruits AXIN1 to the plasma membrane and away
from the destruction complex in the cytoplasm [22]. Thus, the inhibition of β-catenin
phosphorylation results in the accumulation of β-catenin in the cytoplasm, which then
translocates into the nucleus and associates with the TCF/LEF family of transcription factors to
activate β-catenin-dependent responsive genes [24]. Furthermore, both TCF/LEF and β-catenin
interact with additional proteins such as bcl9, Pygopus (PYGO), Pontin, and CBP/p300, to
initiate transcription [17].
Regulation of the canonical Wnt pathway occurs at many points to ensure proper
signaling. Some proteins, such as the secreted Frizzled related protein 1 (Sfrp-1), can act as a
decoy receptor and prevent Wnt signaling initiation by binding to Wnt ligands in the
extracellular membrane, this results in the unspecific inhibition of both canonical and noncanonical Wnt signaling [140]. Other proteins like, Wnt inhibitory factor 1 (Wif-1) and Dickkopf
homologue 1 (Dkk1), specifically inhibit canonical Wnt signaling by binding and blocking the
LRP5/6 co-receptors [17, 140]. Negative regulation also occurs in the nucleus by the cell
autonomous inhibitor of β-catenin and TCF (ICAT), which can inhibit the nuclear interaction
between β-catenin with TCF [25].
Less understood are the two non-canonical Wnt signaling pathways. The PCP pathway
results in Jun N-terminal kinase (JNK) activation, which mediates cell position and shape [17].
It is β-catenin-independent and does not include the Fzd co-receptors LRP5/6 or TCF molecules
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[17]. In this pathway, DVL associates with Disheveled-associated activator of morphogenesis
(DAAM), which activates the RAS homologue gene-family member A (RHOA) and Rhoassociated coiled-coil-containing protein kinase (ROCK) to facilitate cytoskeletal reorganization
[26]. RAC1 is also activated by DVL and both RAC1 and RHOA activate JNK, which leads to
changes in cell adhesion and motility [17]. Keeping in mind that individual pathway activation is
often context specific, the Wnt ligands Wnt-5a and Wnt-11 are known to activate the PCP
signaling pathway through Fzd and DVL in early mouse embryos and likely involves G protein
mediation [141, 142].
A more recently recognized non-canonical Wnt pathway, the Wnt-Ca2+ pathway, is
hypothesized to influence both non-canonical and canonical Wnt signaling [17]. Through a G
protein, the Wnt-Fzd complex activates phospholipase C (PLC), leading to the cleavage of
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) to inositol triphosphate (IP3) and
diacylglycerol (DAG), which then activates protein kinase C (PKC) [17]. IP3 binding to its
receptor on intracellular calcium stores leads to an increase of Ca2+ ion levels in the cytoplasm
[17]. Ca2+ ion levels are normally kept low and the increased Ca2+ concentration activates the
phosphatase calcineurin and several calcium-dependent kinases, including PKC [17]. Increased
calcineurin and PKC have a wide variety of effects but often activates the nuclear factor of
activated T cells (NFAT) [17]. Interestingly, two well-characterized partners in Wnt-Ca2+
pathway initiation are Fzd-2 and Wnt-5a [27, 28], both of which are expressed in TECs.
Currently, Wnt signaling is understood on the assumption that there are three individual
pathways, others however, argue against this divisive approach and instead view all three
pathways as a single Wnt signaling network [29]. They observed that, in vivo, different Wnt
pathways simultaneously regulated each other in the same cell type at the same time—PCP
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signaling activation of JNK has been reported to inhibit the canonical Wnt signaling pathway in
addition to regulating cell movement [17, 29, 143]. They also observed that multiple proteins
were repeatedly involved in different Wnt signaling pathways [29]. For example, Wnt-5a,
thought to be a well-defined stimulator of the non-canonical Wnt-Ca2+ signaling has been shown
to also activate JNK [30]; Wnt-5a also activates β-catenin when in the presence of human Fzd-5
in Xenopus embryos [31] or through mouse Fzd-4 in HEK293 cells [32]. In another study, Wnt3a has been shown to simultaneously activate canonical and non-canonical pathways in the same
cell type [33]. Additionally, the intracellular signaling pathway mediator DVL is involved in βcatenin-dependent signaling, as well as PCP and Wnt-Ca2+ signaling [29]. What is clear is that
Wnt signaling is extremely context specific and, stimulation with a certain Wnt ligand does not
necessarily produce the same results for different cell types in the same species, or the same cell
type in different species, or even in the same cell type in same species but at different time
points. Therefore, it is important to view Wnt signaling as a vast, interconnecting network rather
than individual pathways because making assumptions about specific roles for certain proteins
can lead to invalid conclusions.
Wnt Signaling and Developing Thymocytes
Wnt signaling controls cell fate, self-renewal, proliferation, and survival of HSCs in
addition to the development and homeostasis of adult epithelial tissues. In mouse and human, a
complex patterning of Wnt ligands and Fzd receptors are found in HSCs, lymphocytes, and the
accompanying stromal cells of the HSC microenvironments (the bone marrow and thymus). This
indicates that numerous immune cell types participate in Wnt signaling and that it occurs in both
a paracrine and autocrine fashion. Furthermore, the Wnt pathway plays a major role in the
development, proliferation, and survival of lymphocytes [1, 17]. Although some Wnt ligands
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have been shown to modulate thymocyte development, there are even more with no known
functions detected in thymus.
Thymocytes receive the majority of their Wnt ligands through cross talk with the thymic
epithelium [7]. Though thymocytes themselves express a host of Wnt ligands, albeit at low levels
[1]. Specific thymocyte responsive Wnt ligands and Fzd receptor combinations have yet to be
established. Instead, through a myriad of gain-of-function and loss-of-function transgenic mice, a
greater understanding has been made into the regulation of thymocytes by differential
expressions of intracellular Wnt proteins [1, 17]. Especially the Wnt-responsive transcription
factors TCF1 and LEF1, which are regulated by β-catenin [17, 103, 104]. Transcriptional
activation of TCF1 and LEF1 require protein-protein interaction with β-catenin and this
mechanism is necessary for full thymocyte development [17, 103, 104].
Intrathymic signals regulate the abundance of β-catenin in a developmentally significant
manner and β-catenin directed signaling is highly active in DN proliferation and important for
the transition from DN to DP stages [1, 17]. DN thymocytes naturally increase β-catenin
expression and decrease expression of inhibitory factors like AXIN1, a hallmark of canonical
Wnt signaling activation [1]. In addition, Fzd-6 is predominantly expressed in DN thymocytes
while Fzd-5 is predominantly expressed during DP stages, suggesting that differential expression
of Wnt receptors may aid in proper thymocyte development. [6]. An inhibitor of the β-catenin
TCF/LEF nuclear interaction, ICAT, incompletely blocks thymocyte transition from DN to DP
stages [105]; and a dose-dependent inhibition of canonical Wnt signaling by Dkk1 decreases
thymocyte growth and ultimately prevents development past the DN1 stage [1, 17]. Furthermore,
T-cell specific deletion of β-catenin results in abnormal T-cell development at the DN-DP stage
and reduces the number of peripheral T-cells [108]. By the same token, T-cell specific
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overexpression of β-catenin upregulates proliferation-associated genes in immature thymocytes
and presumably drives their expansion [106, 107]. These studies indicate a prominent role for the
β-catenin-Wnt signaling pathway in early thymocyte development and proliferation.
The transcriptional partners of β-catenin also impact normal thymocyte cellularity and
differentiation. TCF1 and LEF1 double deficient mice have a complete block in T-cell
development at the CD8+ immature single positive (ISP) stage [109]. TCF1 deficient mice
diminish DP thymocyte survival and impair T-cell development from the CD8+ ISP stage to DP
stage [109, 110]. The interaction between β-catenin and TCF1 regulates the expression of CD4
and both DP and CD4+ SP thymocytes in TCF1 deficient mice express lower levels of CD4
[111]. CD4 expression in thymocytes restores to normal levels β-catenin stabilizes [111].
Furthermore, only wild type TCF1, and not truncated isoforms of TCF1 (which lack the domain
necessary for β-catenin interaction), restores CD4 expression in developing thymocytes and
improves DP thymocyte survival [111, 112]. In addition, TCF1 deficient mice develop
lymphomas, attaching an additional role to Wnt signaling proteins as tumor suppressor genes
[114]. Taken together, these reports suggest a significant role for β-catenin-Wnt signaling at
multiple stages of thymocyte development.
Intracellular stabilization of β-catenin in thymocytes depend on the paracrine Wnt signals
TECs secrete and early on, this was determined in two ways. First, DN thymocytes cultured in
the presence of TECs do not show evidence of β-catenin phosphorylation [6]. Once removed
from the thymic stromal environment, however, Wnt signaling deactivates and β-catenin is
phosphorylated and degraded [6]. Second, soluble Fzd receptors used in FTOCS as decoys to
bind to and inactivate Wnt ligands, inhibits thymocyte differentiation by negatively affecting
their proliferation [102]. Together this implies that TEC secretion of Wnt ligands is an important
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event for thymocyte stabilization of β-catenin, but determining the role of specific signals has
been a challenge.
Specific Wnt secreted proteins modulate thymocyte development. Wnt-3a deficient mice
mirrors the phenotypes discovered in TCF1 deficient mice [3]. Wnt-3a often activates β-catenin
signaling and is thought to mediate TCF dependent transcription in developing T-cells [3, 113].
Wnt-3a deficient FTOCs have fewer thymocytes when compared to WT FTOCs [3]. After long
culture periods, the percentage of DP cells in Wnt-3a deficient FTOCs diminishes and there is a
developmental block at the CD8+ ISP stage [3]. Additionally, Wnt-3a signaling affects T-cell
development in a dose-dependent manner, increasing Wnt-3a expression fivefold in transduced
BM stromal cells accelerates T-cell development when compared to control conditions—larger
doses inhibit or block development [113]. Similarly, slightly overexpressing a purified human
WIF1 (a Wnt secreted antagonist) in FTOCs enhances thymocyte cellularity but larger
concentrations decrease cellularity [116]. This suggests that thymocyte sensitivity to certain Wnt
secreted proteins is fine-tuned and likely depends on the developmental stage and the intensity of
the signal.
Wnt-1 deficient or Wnt-4 deficient mice die at birth [56]. Wnt-1 and Wnt-4 double
deficient mice display extremely low fetal thymic cellularity [56]. BM stromal cells transfected
with Wnt-4 expands ETPs and DN thymocytes independently of the thymic microenvironment
[57]. Consistent with this, the tetracycline-induced loss of Wnt-4 in adult TECs decreases thymic
cellularity and disproportionately affects ETPs and DN thymocytes [57]. These data indicate that
the differential expression of specific Wnt ligands have an important role in the survival and
development of thymocytes in both young and adult thymus.
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Finally, non-canonical Wnt signaling also influences the development and survival of
thymocytes. Expressed by the thymic epithelium, Wnt-5a is known to frequently stimulate noncanonical Wnt pathways [2, 113]. Wnt-5a deficient mice die at birth and Wnt-5a deficient
FTOCs increase the percent and total number of SP T-cells. [2]. The loss of Wnt-5a prevents
apoptosis at several stages in thymocyte development through down-regulation of the apoptosis
inducing protein—BCL2-Like Protein 4 (BAX)—and the up-regulation of survival signals like
the apoptosis regulator BCL-2 (an outer mitochondrial membrane protein that blocks apoptotic
death) [2]. The addition of exogenous Wnt-5a reverses thymocyte survival events and promotes
apoptosis in immature DP and mature SP thymocytes [2, 113]. Thus, Wnt-5a modifies thymocyte
survival via the non-conical calcium Wnt pathway and implies that several types of Wnt signals
have significant roles in the establishment of central tolerance [2]. In summary, these
manipulations suggest that Wnt signals, of all kinds, have both profound and subtle effects on the
expansion, survival, and development of thymocytes.
Wnt Signaling and TECs
TECs are the primary source of Wnt secreted proteins in the thymus, which regulates
thymocyte survival and development [7]. Nevertheless, since TECs also express membranebound Fzd receptors, many suspect that they can stimulate Wnt signaling cascades in themselves
[7]. It is difficult, however, to study the effect of Wnt signaling in TECs independent of cross
talk and the indirect influence of developing thymocytes. Few studies have aimed to describe
direct relationships between individual Wnt ligands and their Fzd receptors or the transcriptional
targets Wnt signaling stimulates in TECs. Some studies suggest an important role for canonicalβ-catenin-Wnt signaling in the thymus but seldom considered is the potential impact noncanonical Wnt signaling has on TECs. The expression of several Wnt secreted proteins have

19

been identified in multiple TEC populations but the results vary (in part due to differing
experimental techniques as well as the age, the sex, and the mice used) and most Wnt proteins
detected in the thymus have unknown roles.
Wnt-4, however, has an important role in proper TEC development. Wnt-4 expression in
TECs has been identified in several studies and at multiple time points during thymus
organogenesis, postnatal expansion, and adult homeostasis. Furthermore, Wnt-4 staining colocalizes with EpCAM staining in both human and mouse embryonic TECs suggesting that Wnt4 expression is evolutionary conserved [162]. In fact, the abundant expression of Wnt-4 in the
early thymus highlights the significance of its absence in the aging thymus. By E10.5, the dorsal
and ventral aspects of the 3rd pp already both express the Wnt ligands, Wnt-4 and Wnt-5b, but
differentially express the Wnt inhibitors Wif-1, Nkd1, Sfrp-2 [14, 116]. This implies that Wnt
signaling is spatiotemporally regulated within the 3rd pp and has potential roles in proper
patterning and/or differentiation of the epithelium in early thymus organogenesis [116]. In line
with this, Wnt-4 transgenic mice have been demonstrated to play a role in embryonic thymus
development and migration [134, 56]. The transgenic mice that overexpress Wnt-4 in TECs
disrupted TEC differentiation and resulted in abnormal thymus migration; NLK and β-catenin
were not required to mediate the Wnt-4-induced signaling pathway that disrupted thymus
morphogenesis and suggests that the Wnt-PCP pathway might be involved [134]. Interestingly,
Wnt-4 predominantly affected cTECs and reduced fetal cTEC frequency and cell numbers; fetal
mTEC numbers were similar to controls (though both cell populations were decreased at later
time points when compared to controls) [134]. This implies that Wnt-4 disrupts fetal TEC
differentiation primarily through a cTEC dependent mechanism.
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Wnt-4 is able to trigger both canonical-β-catenin-Wnt and non-canonical-Wnt singling in
a context-dependent manner, and it is the highest expressed Wnt ligand in the 1-month mouse
thymus, expressed in both cTECs and mTECs [7]. Furthermore, Wnt-4 stimulates multiple cell
populations in the thymus as well as prethymic precursors [117]. Through a PCP-like pathway
involving Fzd-6, RAC1, and JNK, Wnt-4 expands hematopoietic progenitors cells derived from
bone marrow and fetal liver [117]. Both conventional and conditional Wnt-4 KO mice suppress
fetal and postnatal thymic expansion and this mutation causes a disproportionate loss of TEPCs,
decreases overall TEC numbers, and alters the medullary-to-cortical TEC ratio [57]. This
suggests Wnt-4 can act through a TEC-dependent mechanism [57]. In another study, Wnt-4
deficient mice substantially decrease the number of thymocytes and, Wnt-4 and Wnt-1 double
deficient mice reduce the number of thymocytes by as much as 50% without the affecting their
pattern of maturation [56]. Wnt-4 transfected BM cells cultured with thymocytes expands ETPs
and DN thymocytes and suggests Wnt-4 is also capable of regulating thymocytes independent of
TECs [57]. Together these data suggest that Wnt-4 dynamically regulates thymic cellularity and
promotes thymopoiesis in multiple cell populations [57].
β-catenin also has an important role in TEC development and its been shown that Wnt-4
and Wnt-1 can each activate the canonical β-catenin-Wnt signaling pathway in TECs [14].
Indeed, canonical β-catenin-Wnt signaling in TECs is a complex and tightly regulated process.
Overexpression or inhibition of β-catenin disrupts normal thymus development. Fetal TECs
transfected with ICAT, inhibits of β-catenin and reduces the expressions of FoxN1, MHC-II, and
IL-7 [162]. A stabilized form of β-catenin, specifically introduced to TECs by a FoxN1
promoter, blocks the early commitment of endodermal epithelia to a thymic fate, the TECs are
unable to recruit thymocytes, and this results in abnormal formation and function of the thymus
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[120]. Mice with a FoxN1 specific deletion of APC stabilized canonical β-catenin-Wnt signaling
and are athymic [118]. Kremen1 (a Wnt antagonist) deficient mice increase canonical β-cateninWnt signaling in TEC derived cell lines, reduce the frequency of cTECs and mTECs in the
thymus, and alter the thymic epithelial architecture, which lack defined cortical and medullary
regions [119]. These data suggest that the stabilization of canonical β-catenin-Wnt signaling in
TECs disrupts the thymus harmfully.
Yet, inhibiting canonical β-catenin-Wnt signaling also disrupts the thymus architecture.
Double transgenic (tetO-Dkk1) mice in the presence of doxycycline produce high levels of Dkk1
in both mTECs and cTECs, this leads to the inducible inhibition of canonical Wnt, a decrease in
TEC proliferation, the reduction of all TEC subsets (including K5+K8+DP TECs thought to
contain TEPCs), and premature thymic degeneration [4]. Consequently, because of their role in
the creation of developing thymocyte niches, Dkk1 inhibition of β-catenin-Wnt signaling also
decreases the number of thymocytes [4]. Taken together, these studies suggest that a precise
regulation of canonical β-catenin-Wnt signaling in TECs is indispensable for proper thymus
development, and enhancing or diminishing canonical β-catenin-Wnt signaling compromises the
integrity of the thymic epithelia.
Mice with a FoxN1 conditional knockout for GPR177, a Wnt-specific cargo receptor
required for secretion of Wnt ligands, loose the capability of all Wnt secretion in TECs,
including both canonical and non-canonical signals. [7]. Without GPR177, TEC cellularity and
thymus size reduces, thymus hypotrophy sets in close to birth, and the number of T-cells in the
periphery reduces [7]. These mice increase the ratio of mature mTEChi to immature mTEClo cell
populations and increase the rate of apoptosis in TECs [7]. Besides that, the mutation does not
affect TEC development, chemokine production, or the differentiation of Aire+ mTECs [7]. It
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does not alter the mTEC/cTEC ratio or thymocyte development, only the thymocyte frequency,
which was less due to the reduced TEC population [7]. Other cell populations in the thymus do
not compensate for the loss of Wnt secretion [7]. This, along with the phenotypes observed in
Wnt-4 deficient mice, argues for a stronger role for Wnt signaling in TEC proliferation and
survival rather than in TEC development and differentiation.
Though, the involvement of Wnt signaling in TEC differentiation cannot be ruled out
completely. Wnt signals are still present in the thymus of GPR177 deficient mice; tDC, tfibroblasts, and even T-cells all express a wide array of low-level Wnt secreted proteins [1, 5,
56]. One can argue, that to some degree, these small amounts of Wnt signals contributed and
facilitated normal T-cell and TEC development in GPR177 deficient mice [1, 5, 56]. Moreover,
Wnt-ligand production by TECs is altered in Aire deficient mice [89]. Wnt-5a, Wnt-7b, and
Wnt-8b are all downregulated in the mTEChi cells of Aire deficient mice when compared to WT
mTEChi cells [89]. Though more conclusive evidence is still needed, this suggests a relationship
between Aire and Wnt signaling. Furthermore, this represents possible roles for Wnt signaling in
the differentiation of mature mTECs, the late processes of thymocyte development, and/or the
emigration of thymocytes from the thymus [89].
Several papers have shown that potential downstream Wnt target genes impact thymus
development. K5 driven expression of CCND1/2, a proposed target gene of Wnt signaling and
FoxN1 [121, 9], in TEPCs causes thymic hyperplasia, expands TEC numbers, and promotes
thymus development [122, 123]. Wnt proteins can regulate STAT3 in ESCs and retinal
epithelium [124, 125] and STAT3 signaling promotes the survival and maintenance of mTECs as
well as the postnatal development of the thymic medullary regions [126, 127]. RAC1 deficient
mice upregulate the expression of c-MYC, another Wnt target gene (though c-MYC is frequently
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regulated by other pathways), which results in thymic atrophy [128]. Together, these data
suggest that potential downstream genetic targets of Wnt signaling influences TEC development.
Wnt Signaling, Thymic Senescence and Age-Related Adipose Involution
Age associated thymic involution, which affects both mice and humans, is characterized
by reduced thymic cellularity, size, and weight [65, 66]. The thymus reaches its maximum size
and T-cell output during adolescence; afterwards, it shrinks and T-cell production sharply
declines [65, 66]. This negatively impacts the function of peripheral T-cell populations, severely
compromises the immune system’s response to newly encountered antigens, and increases the
risk of autoimmunity [36, 9]. Attractively, sex-steroid signaling was believed to have an
important impact on thymic involution since castration studies of male mice display rapid
regrowth of the thymus [8]. Influential findings, however, demonstrate that castration induced
regeneration of the thymus is temporary and that immune dysfunction persist [11].
Instead, FoxN1, the crucial transcription factor required for proper TEC development, has
an undeniable impact on thymus involution. A proportional amount of FoxN1+ TECS and
lymphoid progenitor cells decrease with age; this results in the degeneration of the thymus, the
disruption of normal TEC architecture, and adipocyte development within the thymic and
hematopoietic niches [36, 65, 66]. Retinoblastoma (RB) inactivation prevents thymus involution
through the upregulation of FoxN1 via the E2F transcription factors [37]. Conclusively,
inducible FoxN1 expression in aging TECs vigorously regenerates the thymus so that it mimics
the adolescent in both thymic stromal architecture and gene expression profiles, and increases
thymopoeisis and T-cell output [9].
This is significant because Wnt signaling has been proposed to induce the expression of
FoxN1 in the thymus [14, 162]. E15 murine embryonic lobes, following thymocyte-depletion
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achieved by deoxiguansine-treatment, and incubated in the presence of a Wnt-4 secreting
transgenic cell line increases the expressions of FoxN1, MHC-II, and IL-7 [167]. cTEC and
mTEC cell lines transfected with Wnt-4 and Wnt-5b upregulates FoxN1 but transfection with
Wnt-1 in the same cell lines do not [14]. Though frequently cited, this relationship is still poorly
understood in vivo, and it is not known if the regulation is direct or indirect. For instance, a
recent publication reports that Wnt-4, along with several other Wnt signaling proteins—AES,
Kremen1, and Fzd-5—are possible FoxN1 target genes [15]. In line with this, induced FoxN1
expression in the aged thymus appears to rescue the expression of Wnt-3a, Wnt-4, and Wnt-5b in
cTECs; and the expression of Wnt-7a, Wnt-10a, and Wnt-11 in mTECs [9]. This suggests that
FoxN1 induces Wnt signaling and/or there are multiple feedback loops or undefined mechanisms
involved in the regulation of FoxN1 and Wnt-4. Nevertheless, the loss of FoxN1 expressing
TECs reduces the thymic functional capacity and there is a well-reported correlation between
Wnt-4 and FoxN1 decreased expression in aged TECs [5, 9-10, 54-59].
Wnt-4 and Wnt-5b might regulate, or be regulated by, FoxN1 in early TECs but they also
have additional roles in postnatal expansion, adult TEC homeostasis and age-related thymus
involution [54-59, 9, 11]. Data sets of transcriptional profiles of purified thymocyte and thymic
stromal subsets from mice 1, 3, and 6 months of age reveal that Wnt-3a and Wnt-4 is
downregulated with age in mTEClo cells and cTECs, while Wnt-10a is upregulated with age in
mTEClo cells [5]. FoxN1 is downregulated 2-fold when comparing 1month to 6month old
mTEClo cells and cTECs [5]. Wnt-5b, which may contribute to age-related thymic involution and
adipogenesis, increases expression with age in t-fibroblasts, mTECs, and cTECs [5, 9, 11]. One
drawback to this investigation is that they did not look at late stages of thymic involution (past 6
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months) [5]. Still, these data suggest that certain Wnt signaling members, along with FoxN1, are
deregulated early in thymic involution [5].
In line with this, several studies implicate canonical β-catenin-Wnt signaling in thymic
involution. First, postnatal disruption of TECs by inducible overexpression of the Wnt inhibitor
Dkk1 exhibits reversible thymic atrophy [4]. Second, the production of extracellular Wnt
inhibitors Sfrp-1 and Sfrp-2 increases with age in humans [55]. Third, Wnt receptors Fzd-4, Fzd6, and Fzd-8 have all been shown to increase expression in the aged thymus, though their exact
role is unclear [10, 55]. Finally, overexpressing Wnt-4 prevented the upregulation of adiposerelated differentiation markers like LAP2a in dexamethasone induced thymus senescence [5859].
Wnt signaling is an important regulator of adipogenesis and accordingly, aged-related
adipogenesis of thymic stromal cells likely involves Wnt signaling. In support of this the
treatment of pre-adipocytes with Wnt signaling inhibitors Sfrp-1, Sfrp-2, Sfrp-3, Dkk1, and Wif1 trigger spontaneous differentiation into adipocytes [76]. Furthermore, Wnt4 expression, which
is weakened in aged TECs, is inversely correlated with LAP2a expression [54-59]. LAP2a,
strongly expressed in aged thymic fibroblasts and stromal cells, is thought to initiate epithelialmesenchymal-transition (EMT), a primary cause for cellular transformation into pre-adipocytes
[54]. Wnt-5a/Wnt-5b signaling through the Fzd-2 receptor also regulates EMT in numerous
metastatic cancers [75]. Moreover, LAP2a is synthesized in the cytoplasm before being
transported to the nucleus by a PKC–dependent mechanism [74]. PKC, involved in noncanonical Wnt signaling, also increases expression in the aged thymus [10] and several studies
show that Wnt-5a regulates PKC expression and function in lung development and cancer [7073].
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PPARg, a key transcription factor for pre-adipocyte differentiation is upregulated by
LAP2a, and PPARg expression also increases in the thymus with age [69, 54]. Indeed,
constitutive PPARg activation induces ectopic adipogenesis and promotes age related thymic
involution [36]. This is especially significant because adipocyte differentiation assays show
regulation of PPARg by Wnt-5a, Wnt-4, and Wnt-5b [67, 68]. This suggests that Wnt signaling
has a key part in the age-related upregulation of LAP2a, PPARg, and consequent adipogenesis
[5, 9, 11]. Combined with evidence that the expressions of Wnt-4 and Wnt-5b are deregulated
with age in the thymus, this suggests that Wnt signaling has a significant, if still obscure, role in
thymic senesce and age-associated involution.
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Background and Summary
Prior publications in our lab have demonstrated that proper regulation of Wnt signaling is
important to the maintenance of the postnatal thymus [4, 119]. The inducible overexpression of
Dkk1, which inhibits canonical Wnt signaling, in K5-expressing TECs resulted in rapid thymic
degeneration marked by decreased frequencies of all TEC subsets, including that of Aire+
mTECs [4]. In addition, Kremin1 is required for Dkk1 mediated inhibition of Wnt signaling and
Kremen1 KO mice displayed both, increased canonical Wnt signaling in TECs and reduced
frequencies of cortical and medullary epithelial subsets [119]. Taken together, these data suggest
that the inhibition or overexpression of canonical Wnt signaling both result in the disruption of
the thymic stromal architecture [4, 119]. Thus, our aim was to further explore the role and
regulation of Wnt signaling in the postnatal thymus using TCF/Lef:H2B/GFP transgenic reporter
mice to identify, isolate, and study TECs undergoing active canonical Wnt signaling. We
reported the genetic expression patterns of mTECs undergoing active canonical Wnt signaling
and identified Wnt-5a and Wnt-5b—both of which were regulated by the essential protein for
thymus development, FoxN1—as potential players in this process. TECs are the primary source
of the Wnt secretion proteins expressed in the thymus and we reasoned that the Wnt proteins
expressed by TECs would be able to regulate their development. To this end, we examined
hematopoietic depleted FTOCs stimulated with RANKL to induce Aire expression, in addition to
stimulation with various Wnt proteins to regulate Wnt signaling. Stimulation of FTOCs with
Wnt-5b and Sfrp-1 resulted in reduced mTEC maturation and decreased frequency of Aire+ fetal
TECs. Our results suggest that regulation of Wnt signaling induced by Wnt-5b, which was
expressed by the mature medullary thymic epithelium, can operate in the thymus to govern TEC
differentiation by modulating RANKL-induced expression of Aire+ mTECs.
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Methods
Ethics Statement:
All mice used in this study were bred and maintained at the City college of New York
animal facility and all experiments were performed with approval from the City College of New
York Institutional Animal Care and Use Committee. The animal care facility at the City College
of New York is certified at both the State and Federal levels. The CCNY animal assurance
number is A3733-01.
Mice:
C57BL/6 mice were obtained from the Jackson Laboratory (Bay Harbor, ME). Dr. AnnaKaterina Hadjantonakis (Sloan-Kettering Institute) generously provided TCF/Lef:H2B/GFP mice
which have been previously described [138].
Thymic Stromal Cell Preparation and CD45 Depletion:
To generate single cell suspensions for TEC staining, thymi were removed by surgical
dissections. The thymic lobes were cleaned; all the blood and fat were removed under a
dissection microscope and washed cold PBS. Thymi were cut into 3-4 pieces per lobe and placed
in a 50mL falcon tube with 20mL PBS. Thymi were mechanically agitated by being repeatedly
passed through a glass pipette until the PBS solution was cloudy and the thymic tissue moved
freely through the pipette. The thymic tissue were then digested with a cocktail of DNaseI (50
µg/mL) (7900; StemCell) and collagenase D (1.5 mg/mL) in HBSS media + 5% FBS for
3x15min at 37°C with agitation. Collected supernatants after each round of digestion were
washed with HBSS media + 5% FBS + EDTA (EDTA was added to a final concentration of
5mM and the pH was readjusted to 7.3-7.4) and centrifuged at 1500RPM for 5min at 4°C.
Resuspended cells were passed through a 100µm mesh filter before being counted with a
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hemocytometer. CD45 purified anti-mouse (103102; Biolegend) was then added to the cell
suspension at a concentration of 0.5µL per 1x106 cells and incubated on ice for 10 minutes before
being washed and centrifuged at 1500RPM for 5min at 4°C. The cell pellet was resuspended in
1mL for every 1x107 cells HBSS media + 5% FBS + EDTA for every 1x107 cells and sheep antirat dynabeads (11035; LifeTech) was added at a concentration 25µL per 1x107 cells. Mixture was
gently agitated at 32°C for 20min. CD45 positive cells were removed with a magnet and the
remaining cells were centrifuged at 1500RPM for 5min at 4°C. Cells were resuspended in 1mL
HBSS media + 5% FBS + EDTA, counted, and adjusted to a concentration of 100µL per 1x106
cells in preparation of staining for flow cytometry.
Flow cytometry:
Purified TEC suspensions were incubated with CD16/CD32 Fc block (BD Bioscience) to
block Fc receptors prior to primary staining. Staining of primary antibodies were performed as
indicated in Table 1 on ice, in the dark, for 30min with gentile agitation. Secondary antibodies
were added and cells were incubated for an additional 20min on in the dark with gentile
agitation. After washing, the cells were resuspended in HBSS without FBS for FACS analysis at
a concentration of 2 million cells per 1mL.
Antibody

Conjugation

Working Dilution

CD45

APC Cy-7

(1:1)

MHCII

APC

(1:40)

UEA1

Biotin

(1:5)

EpCAM

PE Cy-7

0.5 µl

CD80

Pacific Blue

7µl

Strepavidin

Per CP Cy-5.5

1µl

CAT# &
Company
557659; BD
Bioscience
17532182;
eBioscience
B-1065; Vector
Labs
25579180;
eBioscience
104725;
Biolegend
45431782
eBioscience
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Data acquisition and cell sorting was performed using a FACS Aria (BD Bioscience). Correct
gating was determined by Fluorescence Minus One (FMO) controls. FACS data was analyzed
using Flow Jo software (Tree Star).
RNA Isolation:
Total RNA was isolated from sorted EpCAM+ medullary thymic epithelial cells or
cultured cells using TRIzol LS reagent (10296010; Invitrogen) according to manufacture’s
guidelines. Further purification of RNA was achieved according to RNAeasy plus micro kit
(74034; Qiagen) protocol and was subjected to gDNA eliminator spin columns. RNA was eluted
with preheated (55°C) RNASE-free water and was analyzed by nanodrop. RNA was either,
stored and combined in -80°C for up to one month for ethanol precipitation or directly
synthesized into cDNA for qRT-PCR.
qRT-PCR:
Equal amounts of RNA were denatured in the presence of random hexamers (N808-0127;
Applied Biosystems) and dNTPs at 65°C for 5 minutes. The denatured RNA was then used to
synthesize cDNA using 5X buffer (y02321; Invitrogen), DTT (y00147; Invitrogen),
SuperScriptIII (18080-044; Invitrogen), and RNase inhibitor (1077-019; Invitrogen) at 25°C for
10 minutes followed by 50°C for 50 minutes and 85°C for 5 minutes. The synthesized cDNA
was subsequently used to preform quantitative real-time PCR using TaqMan universal master
mix (4369016; Applied Biosystems) using the following TaqMan assay probes obtained from
Applied

Biosciences:

(Mm00493214_m1),

18srRNA
DKK1

(4333760),

Foxn1

(Mm00438422_m1),

Aire

(Mm00433948_m1)

EpCAM

(Mm00477461_m1),

Dll4

(Mm00444619_m1), Wnt-5a (Mm00437347_m1), Wnt-5b (Mm01183986_m1). Applied
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Biosystems instrument default cycling protocol was used to perform qRT-PCR using a 7500 RTPCR system.
RNA Precipitation:
RNA samples were defrosted on ice and measured by nano-drop before being pooled
together. The total RNA sample volume was measured and 10% of total RNA volume of sodium
acetate was added to the sample. 100% ethanol at 2.5x the sample volume and 1-2 µg/µl
glycogen for visualization of RNA pellet were also added to the sample. The sample was
vigorously mixed and placed in -80°C overnight. The next day, the sample was centrifuged at
full speed for 20min in 4°C. The sample was aspirated and the pellet was washed twice in 250µl
of 70% ethanol. The ethanol was aspirated and the RNA pellet was air dried in an Rnase-free
environment for 10min. Rnase-free water was added to the pellet and incubated for 10min. The
RNA was mixed by micropipette and analyzed by nanodrop.
PCR Arrays:
Changes in expression of Wnt singling pathway-related genes were detected by using
RT2 Profiler Mouse Wnt Signaling Pathway PCR Array (PAMM-043Z; Qiagen). Each 96-well
plate contained 84 Wnt signaling related genes, one genomic DNA quality control, three reverse
transcription controls, three PCR controls and five housekeeping genes including Actb, B2m,
Gapdh, Gusb, and Hsp90ab1 (B2m was excluded from analysis because of variability between
replicates). Total RNA was extracted from the previously described four distinct mTEC cell
populations (mTECloWnt-, mTECloWnt+, mTEChiWnt-, and mTEChiWnt+) and RNA from at least
three independent experiments (where two mice were used in each experiment) were isolated,
pooled together, and precipitated, as explained above. Two PCR Array Wnt plates were
generated for each mTEC cell population. For each plate, 500ng of RNA was synthesized into
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CDNA with RT2 First Strand Kit (Qiagen). RT2 SYBR Green qPCR Master Mix (Qiagen) was
used for the reaction following manufacture’s instructions. Amplification and real-time analysis
were performed with Applied Biosystems instrument 7500 RT-PCR system and Ct values were
cutoff after cycle 35. Each plate used for analysis passed all three built-in quality controls
demonstrating efficiency of transcription, that no PCR contaminants were detected, and that no
genomic DNA was detected. Analysis of PCR Array results and quality control was performed
using

the

Qiagen

GeneGlobe

Data

Analysis

Center

web

resource

(http://www.qiagen.com/us/shop/genes-and-pathways/technology-portals/qrt-pcr-for-mrnaexpression/data-analysis/~/link.aspx?_id=93C80B99536C4FCDBD1E5FC0759F1324&_z=z).
Fetal Thymic Organ Culture:
Fetal thymic lobes were harvested from E14.5 fetal C57BL/6J mice according to the
protocol previously described (132). Lobes were cultured with RPMI 1640 (GIBCO)
supplemented with 10% FBS (GIBCO), 2mM L-glutamine, 1% glutamax, 1% gentamycin, 1%
nonessential amino acids, 1% sodium pyruvate, and 0.1% 2-ME, and depleted of hematopoietic
cells with 1.35 mM 2`-deoxyguanosine (2-dG) for five days in 6-well transwell culture plates on
polycarbonate isopore filter membranes (0.8µm 13mm) (Fisher Scientific) at 37°C in a
humidified atmosphere of 5% CO2 in air. On the sixth day, fetal thymic lobes were transferred to
fresh medium and cultured for four days with either complete RPMI alone, RANKL (1 µg/mL)
alone (Biolegend), RANKL (1 µg/mL) + Recombinant Mouse sFRP-1 (1 and 0.5 µg/mL),
RANKL (1 µg/mL) + Recombinant Mouse Dkk-1 (1 and 0.5 µg/mL), RANKL (1 µg/mL) +
Recombinant Mouse Wnt-5a (1 and 0.5 µg/mL), RANKL (1 µg/mL) + Wnt-5b (1 and 0.5
µg/mL), RANKL (1 µg/mL) + Wnt-4 (1 and 0.5 µg/mL) (R&D Systems). Fetal lobes were
replenished with media + RANKL + recombinant proteins, where appropriate, every two days.

33

After the nine-day incubation period, fetal thymic lobes were embedded in OCT and snap frozen
in preparation of cryostat sections. At least three lobes were used for each experimental
condition.
Plasmid Transformation, Transfection, and Transduction into TMSC-710 Cells:
Lentiviral plasmid constructs of Dll4 (EX-mM21581-LV215; GeneCopeia) and FoxN1
(EX-mM03018-Lv214; GeneCopeia) were transformed into competent GCL-L3 E. coli cells
(SK300-10) and purified DNA plasmids were isolated from the GCL-L3 E. coli cells according
to company instructions with a Plasmid Midi Kit (Qiagen). The Lenti-Pac HIV Expression
Packaging Kit (HPK-LvTR-20; Genecopia), which included a GFP positive control, and the
purified DNA plasmid constructs containing Dll4 and FoxN1 were used to co-transfect HEK-293
cells according to company guidelines. Infectious lentiviral particles were harvested from the
supernatant of HEK-293 cells 48hrs after transfection and immediately added to semiconfluent
monolayers of TMSC-710’s. After a few days of culture, successfully transduced GFP+ and
mCherry+ cells were isolated with FACS, and stable TMSC-710-CoGFP (empty vector
transduced), TMSC-710-FoxN1 (FoxN1-transduced), and TMSC-710-Dll4 (Dll4-transduced)
cell lines were generated. Cell lines were cultured with thymic stromal culture medium, MEM
alpha (GIBCO) containing 10% FBS, penicillin-streptomycin, and gentamycin supplemented
with recombinant human LIF (10 ng/mL), recombinant mouse EGF (50 ng/mL) and recombinant
bFGF (20 ng/mL) (Invitrogen).
Immunofluorescence:
FTOC lobe tissues were embedded in OCT medium (Fisher); snap frozen and sectioned
(7µm) using a Leica CM1950 Cryostat. Sections were air dried on bond-rite slides and then fixed
in 4% paraformaldehyde followed by 100% ice-cold acetone. Sections were washed with 1%
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PBS and blocked with blocking buffer (5% normal donkey serum in 1% BSA, 0.1% Triton-X)
for 10 minutes. Sections were washed after blocking buffer was applied. Sections were incubated
with appropriately diluted primary antibodies: AIRE (Santa Cruz Laboratories), DEC 205
(138202; Biolegend), and UEA-1 Fluorescein (Vector Laboratories) in blocking buffer in a 4
degree chamber overnight at 4°C. Then, slides were washed with 1% PBS followed by
incubation with secondary reagents diluted in blocking buffer in humidified chamber for 60
minutes at 37°C: TRITC Donkey anti-rat (712-025-150) and Alexa 647 Donkey anti- rabbit
(711-605-152) (Jackson Immuno Research). The slides were then mounted with ProLong gold
anti-fade reagent with DAPI (Invitrogen).
Quantification of number of Aire+ TECs using confocal microscopy:
Frozen sections of fetal thymic tissue were prepared and stained as described above.
Images were acquired using Zeiss LSM710 confocal microscope and analyzed using LSM
software (Zeiss). Confocal images were prepared by scanning each fluorochrome independently
with a 20X lens. For each image, a representative region overlay was manually drawn around the
thymic tissue and the area for this overlay was automatically calculated using LSM software.
The number of Aire+ UEA-1+ nuclei was manually counted within each measured representative
region overlay for each image. DAPI staining was used to confirm that each fluorescent spot
counted was indeed a nucleus. Sections were prepared from throughout the entire lobe to ensure
a comprehensive overview of each lobe. At least 3 lobes were analyzed for each condition and a
minimum of 15 independent calculations derived from 45 sections was used to calculate the
mean and pooled standard deviation of the number Aire+ UEA-1+ TECs for each condition (i.e. 5
independent calculations derived from 15 sections was used to calculate the mean and pooled
standard deviation of the number Aire+ UEA-1+ TECs for each lobe).
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Statistical Analysis:
Statistical analysis was performed as indicated where there were at least three
independent experiments using Student T-test.
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Results
Characterization of mTECs derived from TCF/Lef:H2B/GFP Wnt reporter mice demonstrate
canonical Wnt signaling
β-catenin-dependent or canonical Wnt signaling in the thymus of TCF/Lef:H2B/GFP
Wnt transgenic reporter mice have previously been identified [138]. The TCF/Lef:H2B/GFP Wnt
transgenic reporter mouse has six copies of a TCF/Lef responsive element and a hsp68 minimal
promoter in front of a fluorescent protein fusion comprising human histone H2B to GFP [138].
Nuclear-β-catenin and its transcriptional co-activators, TCF/Lef, interacts with the TCF/Lef
responsive elements to initiate GFP expression and this model is used to visualize cells
undergoing active canonical Wnt signaling at the single-cell level in vivo. Since proper βcatenin-dependent signaling in TECs is crucial for proper thymus development [134], we aimed
to characterize the cell populations undergoing canonical Wnt signaling pathway in the murine
adult thymus of three-month-old male TCF/Lef:H2B/GFP Wnt reporter mice.
We observed significant canonical Wnt signaling in the thymic medulla by
immunofluorescent microscopy (Fig. 1A) and wanted to quantify the GFP reporter expression by
flow cytometer analysis (Fig. 1B). Briefly, thymi harvested from three-month-old male
TCF/Lef:H2B/GFP Wnt reporter mice were enzymatically digested into a single cell suspension
before being partially depleted of CD45+ cells by magnetic beads. The remaining cell suspension
was stained with fluorescent antibodies (CD45, EpCAM, MHC-II, UEA1, and CD80) to separate
TECs from remaining thymocytes and to purify mature and immature TEC populations. CD45EpCAM+MHC-II+ cells are defined as TECs (Fig. 1B). After gating on TECs, further analysis
with UEA-1 allowed separation of EpCAM+UEA1+ mTECs. The mTEC population can be
-

further subdivided, immature mTECs (mTEClo) are defined as MHCloCD80 and more mature

37

mTECs (mTEChi) are defined as MHChiCD80+ (Fig. 1D). TECs that were CD45-EpCAM+MHCII+ UEA-1- contain a population of cTECs (Fig. 1C).
TECs that expressed canonical Wnt signaling are defined as Wnt+ and TECs where
canonical Wnt signaling was undetected are defined as Wnt-. The GFP reporter activity in
mTECs showed that canonical Wnt signaling is differentially expressed in both mTEChi and
mTEClo cell populations. This revealed previously uncharacterized subsets of mTEC populations
that were undergoing active canonical Wnt signaling and allowed for the identification and
analysis of four unique mTEC populations—mTECloWnt-, mTECloWnt+, mTEChiWnt-, and
mTEChiWnt+ (Fig. 1E). The fluorescent intensity of the GFP reporter and the proportion of cells
that were Wnt+ were consistently greater in the mTEChiWnt+ subset when compared to
mTECloWnt+ (Fig. 1E). Most of the immature mTEClo population, ~73%, were Wnt- and roughly
15% were Wnt+. In contrast, only ~48% the mTEChi population was Wnt- and over 43% were
Wnt+ implying a greater frequency of canonical Wnt signaling activity in the mature subset (Fig.
1E). To a lesser degree, we also observed differential expression of canonical Wnt signaling in
the cell population that contains cTECs (Fig. 1C). To substantiate these results, thymi isolated
from C57BL/6 mice, which do not express endogenous GFP in any cell type, were used as a
negative control for the TCF/Lef:H2B/GFP Wnt reporter activity. Using the same single cell
suspension and antibody staining protocols, the mTECs derived from C57BL/6 mice were found
negative for GFP reporter activity (Fig. 1F).
We sought to collect and study the mTEC populations described above for downstream
experiments by a florescent activated cell sorter (FACS). To assess the accurate collections of
mTECs in three-month-old male TCF/Lef:H2B/GFP Wnt reporter mice, we isolated RNA from
mTEClo and mTEChi populations for qRT-PCR analysis of known mature mTEC markers: Aire,
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Dkk1, FoxN1 and EpCAM (Fig. 1G). As expected, genetic expression of all four mature mTEC
markers was detected in both cell populations. The genetic expression levels of Aire and Dkk1
were found to be significantly upregulated (P < 0.05) in mTEChi when compared to mTEClo and
this is consistent with previous findings [4, 5]. The genetic expression levels of FoxN1 and
EpCAM trended higher in mTEChi when compared to mTEClo and while this is also consistent
with previous reports [137], it was not statistically significant. These qRT-PCR results validate
the accurate collection of mTEChi and mTEClo cells for downstream applications.
mTECs derived from TCF/Lef:H2B/GFP Wnt reporter mice differentially express Wnt
signaling proteins
To investigate which genes in the Wnt signaling pathway was active in mTEC Wnt+
cells, we used a Wnt signaling PCR array that simultaneously measures the genetic expression of
84 genes in the pathway. RNA from sorted mTECloWnt-, mTECloWnt+, mTEChiWnt-, and
mTEChiWnt+ populations from at least three independent experiments were isolated, pooled
together, and precipitated. Equal amounts of RNA were then used to synthesize cDNA and two
Wnt PCR array plates were generated for each mTEC population.
We discovered that Wnt ligands and Fzd receptors were differentially expressed in
mTEChi and mTEClo when these populations were separated by canonical Wnt signaling. In
mTEClo, we found that mTECloWnt- was associated with increased expression of Fzd-2, Fzd-3,
Fzd-7, and Wnt-4 as compared to mTECloWnt+ (Fig. 2B). The increase of Wnt-4 expression in
mTEClo compared to mTEChi has been reported before [5, 6, 7], but here we show that within the
mTEClo population Wnt-4 is differentially expressed based only on canonical Wnt activity.
Additionally, we found that mTECloWnt+ was associated with increased expression of Fzd-1,
Fzd-6, and Wnt-5a as compared to mTECloWnt- (Fig. 2B). In mTEChi, we discovered that
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mTEChiWnt- was associated with increased expression of Fzd-1, Fzd-6, and Fzd-7 as compared
to mTEChiWnt+ (Fig. 2A). mTEChiWnt+, on the other hand, was associated with increased
expression of Fzd-3, Fzd-5, and Wnt-5b as compared to mTEChiWnt- (Fig. 2A). Together, these
results argue that within both the mTEClo and mTEChi population there is differential expression
of secreted Wnt ligands and membrane-bound Fzd receptors.
In addition to secreted Wnt ligands and their membrane-bund Fzd receptors, the Wnt
signaling pathway involves numerous cytoplasmic, nuclear, and secreted proteins. We report the
results for these other genes tested by the PCR Array Wnt plate for mTEClo (Fig. 3A) and for
mTEChi (Fig. 3B). Surprisingly, and despite sorting the cells based on canonical Wnt signaling
activity, β-catenin expression levels did not vary greatly between Wnt+ and Wnt- cell populations
(underlined in Fig. 3). In fact, β-catenin expression levels were dwarfed by the expression levels
of Jun and similar to the expression levels of rhoA, both of which are major factors in the noncanonical Wnt-PCP signaling pathway. This suggests that mTECs, in addition to actively
undergoing canonical Wnt signaling, could also be actively undergoing non-canonical Wnt
signaling.
We also report the expression of AES, CCND2, and CSNK1A1 in mTECs and this is
noteworthy because these proteins can potentially influence TEC homeostasis. AES is capable of
inhibiting NF-κB target gene transcription though its interaction with p65 and suggests possible
avenues of cross-regulation between the NF-κB and Wnt singling pathways in mTECs [135].
Mice with K5 driven CCND2 overexpression developed mild thymic hyperplasia that reversed at
4 months [122]. Finally, CSNK1A1 is capable of regulating various proteins in the canonical-βcatenin-Wnt signaling pathway by phosphorylation in both an inhibitory and activating manner,
including that of β-catenin itself [129].
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qRT-PCR confirms the expression of Wnt-5b and Wnt-5a in mTECs
Wnt-5a expression was increased in mTECloWnt+ when compared to mTECloWnt- (Fig.
2B), and Wnt-5b expression was increased in mTEChiWnt+ when compared to mTEChiWnt- (Fig.
2A). Therefore, we chose to further study Wnt-5a and Wnt-5b in the thymus due to their
differential expression levels in Wnt+ cell populations. Wnt-5a has a known function in the
thymus and drives apoptosis in DP thymocytes [2], while Wnt-5b is thought to be capable of
driving FoxN1 expression in the thymus [7]. Furthermore, both Wnt-5a and Wnt-5b have been
implicated in stimulating adipogenesis and thus could have a possible role in thymic senescence
and age-related adipose involution [67, 68]. In addition, Wnt-5a and Wnt-5b are capable of
working in unison—they can coordinate chondrocyte proliferation and differentiation in bone
development by differentially regulating gene transcription [136]. We hypothesized that a similar
mechanism might be present in the thymus to coordinate TEC proliferation and differentiation.
We used qRT-PCR to confirm the results from the Wnt PCR array analysis regarding
Wnt-5a and Wnt-5b expression. RNA derived from sorted EpCAM+ cells was used as a positive
control and qRT-PCR analysis of the four unique mTEC cell populations revealed that Wnt-5a
was significantly upregulated (~4-fold) in the mTECloWnt+ subset when compared to the other
mTEC subsets (Fig. 4A). Moreover, the genetic expression level of Wnt-5b was also found to be
significantly upregulated (~6-fold) in the mTEChiWnt+ cell population when compared to the
other mTEC subsets (Fig. 4B). These results are consistent with the results reported in the Wnt
PCR array analysis and suggest a possible role for these ligands in the regulation of Wnt
signaling in mTECs.
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Wnt secretion proteins modulate RANKL-induced expression of Aire in FTOCs independent
of thymocytes
As freshly isolated TECs are not suited to manipulations in vitro due to their rapid loss of
TEC-specific features, we used E14.5 fetal thymic epithelial cultures to investigate the role of
Wnt secretion proteins in TEC development [160]. FTOCs were prepared with 2`-dG to remove
hematopoietic cells while leaving the TECs relatively unharmed. RANKL directly and
specifically induces the expression of Aire in fetal TECs and fetal TECs were cultured with both
RANKL (to induce TEC maturation) and different Wnt signaling inhibitors or Wnt ligands
(Table 1) [91]. We then measured how Wnt secretion proteins influenced maturation by
assessing the frequency of Aire+UEA-1+DEC-205- TECs by immunofluorescent microscopy.
Lobes cultured with only RPMI media after hematopoietic cell depletion were used as negative
controls. We did not detect the presence of any Aire+ cells in the negative controls, indicating
that all hematopoietic cells were successfully removed from the fetal lobes (Fig. 6). With the
absence of hematopoietic cells, all induced Aire expression would be initiated by exogenous
RANKL and lobes treated with RANKL alone were used as positive controls (Fig. 6).
Wnt Inhibitors and Ligands
Sfrp-1

Inhibitor of canonical and non-canonical Wnt
signaling
Dkk1
Specific inhibitor of canonical Wnt signaling
Wnt-4
Regulates thymic cellularity and possibly FoxN1
expression; decreased expression with age
Wnt-5b
Increased expression with age; possible role in agerelated adipogenesis
Wnt-5a
Induces apoptosis in thymocytes; possible role in agerelated adipogenesis
Table 1. Wnt inhibitors and ligands used in FTOCs.

We aimed to demonstrate that secreted Wnt proteins would be able to impact the
RANKL-induced development of TECs. Therefore, we chose to culture fetal TECs with Sfrp-1,
an antagonist that directly binds to Wnt ligands that was also upregulated in the aged human
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thymus as well as being implicated in thymic senescence and age-related adipose involution [55].
In FTOCs, Sfrp-1 should disrupt both canonical and non-canonical Wnt signaling by interfering
with endogenous Wnt ligands produced by fetal TECs. However, the ability of Sfrp-1 to inhibit
both canonical and non-canonical Wnt ligands means we cannot determine which pathway
influenced TEC development. Yet, since Sfrp-1 is also capable of blocking the interaction of
RANKL with its receptor directly, we anticipated Sfrp-1 would influence RANKL-induced Aire
expression in some way and thus demonstrate that the secretion of Wnt proteins were capable of
impacting TEC development [131]. Indeed, fetal lobes treated with RANKL and Sfrp-1
significantly reduced the frequency of Aire+UEA-1+DEC-205- TECs at both concentrations (Fig.
5A). Sfrp-1 does not seem to interfere with RANKL-induced expression of Aire in TECs in a
dose-dependent manner. Sfpr-1 negatively impacted RANKL-induced expression of Aire in fetal
TECs and these results suggest that certain secreted Wnt proteins are capable of modulating the
development and maturation of the thymus.
To determine whether the decrease in the frequency of Aire+UEA-1+DEC-205- TECs
may be attributed to canonical or non-canonical Wnt signaling, we tested the effect of coculturing Dkk1 with RANKL in FTOCs. Dkk1 specifically inhibits canonical Wnt signaling by
blocking the interaction between Fzd and its co-receptor LRP—it does not directly interfere with
non-canonical Wnt signaling. A reduction in the frequency of Aire+UEA-1+DEC-205- TECs in
fetal lobes treated with RANKL and Dkk1 could suggest that the inhibition of canonical-Wnt
signaling negatively effects the development and maturation of fetal TECs. However, we
observed no difference with regards to the frequency of Aire+UEA-1+DEC-205- TECs in samples
treated with Dkk1 when compared to the RANKL-only positive controls (Fig. 5B). This
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indicates that the inhibition of canonical Wnt signaling, independent of thymocytes, is indifferent
to the process of RANKL-induced expression of Aire in fetal TECs.
Next, we asked if stimulating fetal TECs with secreted Wnt ligands were capable of
affecting RANKL-induced maturation. Wnt-4 is highly active at multiple time points during
thymus development and its absence in the aged thymus is thought to contribute to thymic
senescence. Strong Wnt-4 expression in adult TECs has been demonstrated here (Fig. 3) and in
other reports [5, 7]. Wnt-4 is also able to trigger both canonical-β-catenin-Wnt and noncanonical-Wnt singling in a context-dependent manner, and has previously been demonstrated to
play a role in embryonic thymus development and migration [134, 56]. Here, we report that Wnt4 did not lessen RANKL-induced expression of Aire in fetal TECs (Fig. 5C). Instead, the
frequency of Aire+UEA-1+DEC-205- TECs in fetal lobes treated with RANKL and Wnt-4 (for
both concentrations) consistently trended higher than that in the RANKL-only positive
controls—but it was not statistically significant (Fig. 5C). Nonetheless, FTOCs stimulated with
Wnt-4 had the highest measured frequency of Aire+UEA-1+DEC-205- TECs and this might
suggest that Wnt-4 supports mTEC differentiation. At the very least, these results indicate that
Wnt-4 does not negatively influence RANKL-induced Aire expression in fetal TECs.
Wnt-5b is thought to drive the expression of FoxN1 [14], its expression has been reported
to increase in t-fibroblasts, mTECs, and cTECs with age [5, 9, 11], and we showed evidence that
Wnt-5b is expressed at higher levels in the mature mTEChiWnt+ population (Fig. 2A).
Furthermore, keratinocyte growth factor (KGF) enhanced postnatal T-cell development, TEC
proliferation and function, and increased TEC expression of Wnt-5b, suggesting that Wnt-5b
might be important for the maintenance of the thymus [160]. Remarkably, FTOCs treated with
Wnt-5b resulted in a severely reduced frequency of Aire+ UEA-1+ DEC-205- TECs in fetal lobes
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in a dosage-dependent manner (Fig. 5D). After 4 days of co-culturing RANKL with 500ng/mL
of Wnt-5b, the frequency of Aire+ UEA-1+ DEC-205- TECs dropped more than 35% when
compared to positive controls (Fig. 5D). Increasing the concentration of Wnt-5b to 1µg/mL
resulted in an even more profound decrease in the frequency of Aire+ UEA-1+ DEC-205- TECs,
which was reduced ~70% when compared to positive controls (Fig. 5D). The decrease in the
frequency of Aire+ UEA-1+ DEC-205- TECs in the absence of hematopoietic cells indicates that
Wnt-5b exerts its effect directly on fetal TECs. These results strongly suggest that the secreted
Wnt-5b ligand obstructs RANKL-induced Aire expression and that certain Wnt ligands can
regulate thymus development and fetal TEC maturation.
In the mTEClo Wnt+ population we discovered strong Wnt-5a mRNA expression (Fig.
2B). Furthermore, Wnt-5a induces apoptosis in thymocytes [2] and we hypothesized if it could
also reduce the frequency of Aire+ UEA-1+ DEC-205- TECs by inducing apoptosis in fetal TECs.
Instead, FTOCs treated with Wnt-5a did not change the frequency of Aire+ UEA-1+ DEC-205TECs at either concentration and were similar to positive controls (Fig. 5E). This suggests that
Wnt-5a does not induce apoptosis in fetal TECs and does not influence RANKL-initiated TEC
development.
Lastly, on average, samples treated with Wnt inhibitors Dkk1 and Sfrp-1 were measured
at about the same area size as RANKL positive controls (Fig. 5F). This suggests that in the
absence of thymocytes, Wnt inhibition did not alter TEC cellularity. However, samples treated
with Wnt ligands (with the exception of Wnt-5b 500ng/mL) were, on average, reduced in
measured area size. In particular, Wnt-4 treated samples were the lowest measured fetal tissue
area sizes, yet induced mTEC maturation by RANKL appeared unaffected (Fig. 5F). This is
consistent with the recent publication that described transgenic mice overexpressing Wnt-4
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reduced overall embryonic TEC numbers, particularly by disturbing fetal cTEC development,
while indifferent to fetal mTEC development [134].
FoxN1 and Dll4 regulate Wnt-5a and Wnt-5b genetic expression
Once we confirmed the presence of Wnt-5a and Wnt-5b in Wnt+ mTECs in the adult
male thymus and saw that Wnt-5b modulated RANKL-induced maturation of fetal TECs, we
examined their possible role in response to two hallmark genes of thymic development: FoxN1
and Dll4. Mesenchymal stem cells derived from the thymus capable of differentiating into other
cell linages—such as osteocytes, chondrocytes, and adipocytes—known as TMSC-710’s, have
been described in a previous publication from our lab [130]. We transformed the TMSC-710
cells with lentivirus particles containing a FoxN1-mCherry gene vector, a Dll4-GFP gene vector,
or a control-GFP (CoGFP) vector. TMSC-710 cells that successfully integrated the FoxN1 vector
into its genome were visualized with mCherry and cells that successfully integrated the Dll4GFP vector were visualized GFP. Both samples were then sorted and purified by FACS for cell
culturing.
We quantified the relative expression of Dll4 and FoxN1 in TMSC-710-FoxN1, TMSC710-Dll4, and in TMSC-710-CoGFP using qRT-PCR. TMSC-710-FoxN1 had ~7-fold higher
expression of FoxN1 when compared with either TMSC-710-CoGFP or TMSC-710-Dll4 (Fig.
7A). TMSC-710-Dll4 had ~35-fold higher expression of Dll4 when compared with TMSC-710CoGFP or TMSC-710-FoxN1 (Fig. 7B). Together, this demonstrated successful transformation
of Dll4 and FoxN1 into these cell lines.
Next, we analyzed the genetic expression of Wnt-5a and Wnt-5b in these transformed cell
lines. When compared to TMSC-710-CoGFP cells, TMSC-710-Dll4 cells significantly
downregulated Wnt-5b genetic expression levels, while there was no change in Wnt-5a
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expression (Fig. 7C). TMSC-710-FoxN1 cells significantly upregulated Wnt-5b 3-fold and
simultaneously, significantly downregulated Wnt-5a genetic expression levels when compared
TMSC-710-CoGFP cells (Fig. 7C). The FoxN1 driven upregulation of Wnt-5b in TMSC-710FoxN1 argues that FoxN1 is capable of driving Wnt signaling. This finding is supported by
previous publications showing that induced FoxN1 expression in the aged thymus rescued the
expression of Wnt-5b in cTECs [9]. Together with the previous report that Wnt-5b upregulated
FoxN1, it is conceivable that Wnt and FoxN1 are a part of a positive feedback loop regulating
Wnt signaling in TECs [14]. These results suggest FoxN1 and Dll4 can significantly regulate the
expression of Wnt ligands and thus regulate Wnt signaling in the thymus.
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Future Work
Immediate future projects will investigate in more detail 2 important issues related to our
findings in fetal TECs: (1) the regulation in the expression of differentiation and survival factors;
and (2) the signal transduction pathway in TECs activated by Wnt secretion proteins.
Specifically, we aim to address the molecular mechanisms involved in the Wnt-5b and Sfrp-1
modulation of RANKL-induced Aire expression in fetal TECs. Currently, it was not clear how
the manipulation of Wnt signaling in FTOCs altered TEC development. In Wnt-4 transgenic
mice, TEC profiles revealed that Wnt-4 altered proper TEC differentiation and increased the
frequency of an undefined TEC population [134]. It is possible that our Wnt manipulation fetal
TECs behaved similarly and augmented an atypical TEC population and, therefore, it is
imperative to consider if and how the mTEC/cTEC ratio was altered. Likewise, our Wnt
manipulation might have increased the rate of apoptosis in TECs, as was the case with Wnt-5a
and thymocyte development [2]. Or rather, the manipulation of Wnt signaling in fetal TECs
could have reduced TEC survival without increasing apoptosis, as was the case in FoxN1Gpr177 KO mice where the secretion of Wnt proteins was blocked [7]. On the other hand, Wnt5b might be driving mTEC differentiation, and when combined with RANKL, might be pushing
the cells to terminal differentiation at increased rates.
Wnt signaling may have a direct affect on regulating the NF-κB pathway. AES, which we
identified to be expressed in the mTEC subsets, was also revealed to be a potent inhibitor of NFκB-dependent gene expression [157]. Specifically through a protein-protein interaction with the
p65 (RelA) subunit, a transcription factor of NF-κB, AES repressed p65-driven gene expression
and inhibited NFKB-dependent gene expression induced by TNFα, interlukin-1β, or MEKK1
[157]. However, RelA was also reported to be involved in the down-regulation of canonical Wnt
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signaling and likely mediated β-catenin suppression after the binding of the β-catenin/TCF
complex with target DNA since RelA did not disturb the nuclear import of β-catenin nor its
DNA-binding ability [144, 158]. This suggests that there may be competition between the Wnt
pathway and the NF-κB pathway for gene transcription in TECs.
Tnfrsf19 expression, a member of the TNFSF receptors, was shown to be a direct target
of canonical Wnt signaling [159]. Tnfrsf19 induced NF-κB signaling through interaction with
Traf6, which was shown to be essential for mature mTEC differentiation [161]. Furthermore,
increased expression of Tnfrsf19 in the ventral aspect of 3rdpp of the developing thymus was
reported and it was proposed that Tnfrsf19 is targeted by Wnt signaling in the fetal thymus to
induce Traf6 via the NF-κB pathway to promote the differentiation of thymic epithelial
progenitors into an mTEC cell fate [116]. If so, this process might be disrupted by Sfrp-1 or
Wnt-5b ectopic expression leading to decreased TEC maturation. Interestingly, Wnt-4 and Wnt5b are also highly expressed in the ventral aspect of 3rdpp at this time [116].
Keratinocyte growth factor (KGF), increased TEC expression of Wnt-5b and Wnt-10b in
the adult thymus and enhanced TEC proliferation and function; it was also revealed that this was
highly dependent on NF-κB signaling and thus, linking Wnt-5b to the NF-κB signaling pathway
[160]. In contrast to the results in the postnatal thymus, KGF failed to drive the expression of
Wnt-5b in the fetal thymus [160]. However, KGF was able to drive Wnt-10b expression in the
fetal thymus where it increased TEC proliferation [160]. The divergence of KGF driving the
expression Wnt-5b in the postnatal thymus but not the fetal thymus was attributed to the
differences in maturation of the TECs [160]. This suggests that the regulatory relationship
between NF-κB signaling and Wnt signaling could change based on the level of maturity of the
TECs [160].
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Wnt signaling in the thymus is very complex and likely involves both canonical and noncanonical pathways at the same time. We will investigate the signal transduction pathway
activated by Wnt-5b and repressed by Sfrp-1 to determine if TEC development was modulated
through canonical or non-canonical Wnt pathways or both. Our data indicates that Wnt-5b might
be involved in the regulation of canonical Wnt signaling since its expression was localized to
mTEChiWnt+. Despite this, Wnt-5b and Wnt-5a are commonly referred to as ‘classical’ noncanonical Wnt ligands and often work together in several cell types. In mice, Wnt-5b and Wnt-5a
coordinated chondrocyte proliferation and differentiation by differentially regulating downstream
target genes [136] and Wnt-5b was later shown to regulate mesenchymal and chondrocyte
differentiation through the PCP signaling pathway [148]. In addition, Wnt-5b and Wnt-5a
promoted osteogenic differentiation in Rat tendon-derived stem cells through the activation of
the PCP-JNK signaling pathway [153]. Furthermore, Wnt-5a, Wnt-5b, and Sfrp-1 together with
intracellular signaling via PCP proteins, polarized node cells of the mouse embryo along the
anterior-posterior axis for breaking of left-right symmetry [154].
It is not always the case, however, that Wnt-5b always activates the PCP pathway. In
zebra fish, gastrulation movement required the Wnt-Ca2+ signaling pathway, which was initiated
by Wnt-5b involving the receptor tyrosine kinase (Ryk) and the Fzd-2 receptors [147, 151],
while osteoclast differentiation was also mediated by Wnt-5b through Ryk [152]. Interestingly,
Wnt-5b is also known to inhibit β-catenin-dependent transcription—in murine preadipocyte
differentiation and adipogenesis Wnt-5b, through an unknown mechanism, impaired β-catenin
nuclear translocation [68].
And yet, in other studies, Wnt-5b either stimulates canonical Wnt signaling or has been
suggested to. In a human, lung derived fibroblasts cell line; Wnt-5a, Wnt-5b, RhoA, Fzd-2, and
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β-catenin were all upregulated in response to bFGF in a concentration and time dependent
manner [155]. Wnt-5b, Wnt-5a, Wnt-4, Wnt-11 and β-catenin are all expressed during bone
fracture repair, which suggested that β-catenin-dependent transcription was activated [149].
Moreover, Wnt-5b triggered β-catenin signaling in triple negative breast cancer cells and
increased TCF transcription activity by 30%, while knocking-down Wnt-5b in these cells
reduced TCF transcription activity by 50% [150]. Finally, in zebrafish, lymphatic progenitors
arise from angioblasts induced directly by Wnt-5b through the canonical Wnt pathway—and
since Wnt-5b also induced the angioblast-to-lymphatic transition in human embryonic cells,
implied that it did so through activating the canonical Wnt signaling pathway [156]. Thus, Wnt5b is capable of activating the non-canonical Wnt signaling pathways—both the PCP and WntCa2+ pathways—and can also activate and inhibit canonical Wnt signaling.
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Figures
Legends
Figure 1: Characterization of TCF/Lef:H2B/GFP Wnt activity in the postnatal thymus and
representative TEC sorting gating hierarchy.
(A) TCF/Lef:H2B/GFP Wnt activity is localized to the medulla (UEA-1+) in the thymus and not
the cortex (Dec-205+). (B) Strategy for sorting TEC populations by flow cytometer cell sorter in
3 month old male TCF/Lef:H2B/GFP Wnt reporter mice. mTECs are defined as EpCAM+MHCII+UEA-1+CD45-. (C) EpCAM+UEA-1- cells contain the cTEC population which has low
TCF/Lef:H2B/GFP Wnt activity. (D) mTECs are divided into two cell populations: CD80-MHCII-lo describes mTEClo and CD80+MHC-IIhi describes mTEChi. (E) GFP Wnt reporter mice
allow for further separation of mTEClo and mTEChi into mTECloWnt-, mTECloWnt+,
mTEChiWnt-, and mTEChiWnt+. (F) TECs derived from three-month-old C57BL/6 mice were
used as a negative control for properly gating GFP Wnt reporter activity. (G) qRT-PCR analysis
of mature mTEC markers (EpCAM, FoxN1, Dkk1, and Aire) in FACS sorted mTECs. Data are
normalized to the housekeeping control gene 18s and relative to mTEChi. Equal starting amounts
of RNA were synthesized into cDNA. Experiment was repeated 3 times and included NTC and
NRT controls. Error Bars ±SEM. Asterisks indicate P < 0.05 (Students t test).
Figure 2: Relative mRNA expression of detected WNT ligands and FZD receptors in
mTECs.
Differential genetic expression of Wnt ligands and FZD receptors in (A) mTEClo and (B)
mTEChi, Wnt+ and Wnt- cell populations. RNA isolated from 3 independent experiments was
pooled together and equal amounts (500ng) were used for each cDNA synthesis reaction. cDNA
were then loaded onto Wnt PCR-Array plates and gene expression was assessed by Applied
Biosystems instrument 7500 RT-PCR system. Ct values were cutoff at cycle 35 and the 2-Δct
relative quantification method was applied to calculate the expression values. Gene-of-interest
expression levels are relative to the geometric mean of the expression of four housekeeping
genes (Actb, Gapdh, Gusb, & Hsp90ab1) in the same sample. Graphs represent the mean of two
independent PCR-Array experiments and only genes where trends were similar were included.
Figure 3: Relative mRNA expression of Wnt signaling proteins.
Differential genetic expression of Wnt signaling proteins in (A) mTEClo and (B) mTEChi, Wnt+
and Wnt- cell populations. RNA isolated from 3 independent experiments was pooled together
and equal amounts (500ng) were used for each cDNA synthesis reaction. cDNA were then
loaded onto Wnt PCR-Array plates and gene expression was assessed by Applied Biosystems
instrument 7500 RT-PCR system. Ct values were cutoff at cycle 35 and the 2-Δct relative
quantification method was applied to calculate the expression values. Gene-of-interest
expression levels are relative to the geometric mean of the expression of four housekeeping
genes (Actb, Gapdh, Gusb, & Hsp90ab1) in the same sample. Graphs represent the mean of two
independent PCR-Array experiments and only genes where trends were similar were included.
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Figure 4: qRT-PCR of Wnt5a and WNT5b expression levels in sorted TECs. (A)
WNT5a expression was realtive to the housekeeping control gene 18s in mTECloWnt-,
mTECloWnt+, mTEChiWnt-, and mTEChiWnt+. (B) WNT5b expression was relative to the
housekeeping control gene 18s in in mTECloWnt-, mTECloWnt+, mTEChiWnt-, and mTEChiWnt+.
Data are normalized to the expression in the positive control EpCAM+ sorted thymic cells. Equal
amounts of starting RNA were synthesized into cDNA. Experiments were performed in triplicate
repeats and repeated 3 times. Experiments included no-template negative controls and no-reverse
transcriptase negative controls. * P < 0.05 (Students t test). Error Bars ±SEM
Figure 5: Secreted WNT proteins modulate RANKL-induced Aire expression in Fetal
TECs.
E14.5 fetal thymic lobes were isolated from pups and were cultured with 1.35mM 2-dG + RPMI
medium for 5 days to deplete them of hematopoietic cells. Lobes were then treated with either
RANKL (1ug/mL), (A) RANKL + Sfrp-1, (B) RANKL + Dkk1, (C) RANKL + Wnt-4, (D)
RANKL + Wnt-5b, and (E) RANKL + Wnt-5a and analyzed for the mean number of Aire+
UEA-1+ DEC-205- nuclei (confirmed by DAPI) per mm2 of measured fetal thymic tissue. (F)
Average measured area (mm2) of imaged thymic tissue sections. At least 15 sections from 3
individual lobes were analyzed for each condition. Therefore, a minimum of 15 independent
calculations derived from 45 sections was used to calculate the mean and pooled standard
deviation (±SD) of the number Aire+UEA-1+DEC-205- TECs for each condition. Asterisks
indicate P < 0.001 (Students t test).
Fig 6: Representative FTOC images.
RANKL-induced development of Aire+UEA-1+DEC-205- fetal TECs in E14.5 FTOCs post
hematopoietic depletion and subsequent co-culturing with Wnt secreted proteins.
Figure 7: FOXN1 and DLL4 influence WNT5a and WNT5b expression.
(A) qRT-PCR analysis of FoxN1 expression in transformed TMSC-710 cell lines. (B) qRT-PCR
analysis of Dll4 expression in transformed TMSC-710 cell lines. (C) qRT-PCR analysis of Wnt5a and Wnt-5b in transformed TMSC-710 cell lines. For (A) and (B), experiments were
performed on three occasions, representative experiments are shown. For (C), graph represents
the average of three independent experiments performed in technical triplicates. Equal amounts
of RNA (500ng) were synthesized into cDNA with reverse transcriptase. Data are normalized to
TMSC-710-CoGFP and relative to the control housekeeping gene 18s. * P < 0.05; ** P < 0.01
(Students t test). Error Bars ±SEM
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